The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-infective API Market Research Report 2025
Synopsis
The global Anti-infective API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-infective API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-infective API.
Report Scope
The Anti-infective API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-infective API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-infective API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz
Segment by Type
β-lactam Drugs
Macrolides
Carbapenems
Quinolones
Segment by Application
Antibacterial Drugs for Systemic Use
Antiviral Drugs for Systemic Use
Antigen for Whole Body
Bacteria
Immune Serum and Immunoglobulin
Anti-mycobacterial Drugs
Vaccine
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-infective API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Anti-infective API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Anti-infective API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Anti-infective API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-infective API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-infective API.
Report Scope
The Anti-infective API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-infective API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-infective API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz
Segment by Type
β-lactam Drugs
Macrolides
Carbapenems
Quinolones
Segment by Application
Antibacterial Drugs for Systemic Use
Antiviral Drugs for Systemic Use
Antigen for Whole Body
Bacteria
Immune Serum and Immunoglobulin
Anti-mycobacterial Drugs
Vaccine
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-infective API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Anti-infective API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Anti-infective API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Anti-infective API Market Overview
1.1 Product Definition
1.2 Anti-infective API Segment by Type
1.2.1 Global Anti-infective API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 β-lactam Drugs
1.2.3 Macrolides
1.2.4 Carbapenems
1.2.5 Quinolones
1.3 Anti-infective API Segment by Application
1.3.1 Global Anti-infective API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Antibacterial Drugs for Systemic Use
1.3.3 Antiviral Drugs for Systemic Use
1.3.4 Antigen for Whole Body
1.3.5 Bacteria
1.3.6 Immune Serum and Immunoglobulin
1.3.7 Anti-mycobacterial Drugs
1.3.8 Vaccine
1.3.9 Other
1.4 Global Market Growth Prospects
1.4.1 Global Anti-infective API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Anti-infective API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Anti-infective API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Anti-infective API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Anti-infective API Production Market Share by Manufacturers (2019-2024)
2.2 Global Anti-infective API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Anti-infective API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Anti-infective API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Anti-infective API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Anti-infective API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Anti-infective API, Product Offered and Application
2.8 Global Key Manufacturers of Anti-infective API, Date of Enter into This Industry
2.9 Anti-infective API Market Competitive Situation and Trends
2.9.1 Anti-infective API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Anti-infective API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Anti-infective API Production by Region
3.1 Global Anti-infective API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Anti-infective API Production Value by Region (2019-2030)
3.2.1 Global Anti-infective API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Anti-infective API by Region (2025-2030)
3.3 Global Anti-infective API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Anti-infective API Production by Region (2019-2030)
3.4.1 Global Anti-infective API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Anti-infective API by Region (2025-2030)
3.5 Global Anti-infective API Market Price Analysis by Region (2019-2024)
3.6 Global Anti-infective API Production and Value, Year-over-Year Growth
3.6.1 North America Anti-infective API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Anti-infective API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Anti-infective API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Anti-infective API Production Value Estimates and Forecasts (2019-2030)
4 Anti-infective API Consumption by Region
4.1 Global Anti-infective API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Anti-infective API Consumption by Region (2019-2030)
4.2.1 Global Anti-infective API Consumption by Region (2019-2024)
4.2.2 Global Anti-infective API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Anti-infective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Anti-infective API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Anti-infective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Anti-infective API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Anti-infective API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Anti-infective API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Anti-infective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Anti-infective API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Anti-infective API Production by Type (2019-2030)
5.1.1 Global Anti-infective API Production by Type (2019-2024)
5.1.2 Global Anti-infective API Production by Type (2025-2030)
5.1.3 Global Anti-infective API Production Market Share by Type (2019-2030)
5.2 Global Anti-infective API Production Value by Type (2019-2030)
5.2.1 Global Anti-infective API Production Value by Type (2019-2024)
5.2.2 Global Anti-infective API Production Value by Type (2025-2030)
5.2.3 Global Anti-infective API Production Value Market Share by Type (2019-2030)
5.3 Global Anti-infective API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Anti-infective API Production by Application (2019-2030)
6.1.1 Global Anti-infective API Production by Application (2019-2024)
6.1.2 Global Anti-infective API Production by Application (2025-2030)
6.1.3 Global Anti-infective API Production Market Share by Application (2019-2030)
6.2 Global Anti-infective API Production Value by Application (2019-2030)
6.2.1 Global Anti-infective API Production Value by Application (2019-2024)
6.2.2 Global Anti-infective API Production Value by Application (2025-2030)
6.2.3 Global Anti-infective API Production Value Market Share by Application (2019-2030)
6.3 Global Anti-infective API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 North China Pharmaceutical
7.1.1 North China Pharmaceutical Anti-infective API Corporation Information
7.1.2 North China Pharmaceutical Anti-infective API Product Portfolio
7.1.3 North China Pharmaceutical Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 North China Pharmaceutical Main Business and Markets Served
7.1.5 North China Pharmaceutical Recent Developments/Updates
7.2 CSPC
7.2.1 CSPC Anti-infective API Corporation Information
7.2.2 CSPC Anti-infective API Product Portfolio
7.2.3 CSPC Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 CSPC Main Business and Markets Served
7.2.5 CSPC Recent Developments/Updates
7.3 Harbin Pharmaceutical Group Pharmaceutical General Factory
7.3.1 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Corporation Information
7.3.2 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product Portfolio
7.3.3 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Harbin Pharmaceutical Group Pharmaceutical General Factory Main Business and Markets Served
7.3.5 Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Developments/Updates
7.4 Henan Huaxing Pharmaceutical Factory
7.4.1 Henan Huaxing Pharmaceutical Factory Anti-infective API Corporation Information
7.4.2 Henan Huaxing Pharmaceutical Factory Anti-infective API Product Portfolio
7.4.3 Henan Huaxing Pharmaceutical Factory Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Henan Huaxing Pharmaceutical Factory Main Business and Markets Served
7.4.5 Henan Huaxing Pharmaceutical Factory Recent Developments/Updates
7.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
7.5.1 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Corporation Information
7.5.2 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product Portfolio
7.5.3 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Main Business and Markets Served
7.5.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Developments/Updates
7.6 Zhangjiakou Diha Pharmaceutical
7.6.1 Zhangjiakou Diha Pharmaceutical Anti-infective API Corporation Information
7.6.2 Zhangjiakou Diha Pharmaceutical Anti-infective API Product Portfolio
7.6.3 Zhangjiakou Diha Pharmaceutical Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Zhangjiakou Diha Pharmaceutical Main Business and Markets Served
7.6.5 Zhangjiakou Diha Pharmaceutical Recent Developments/Updates
7.7 Shandong Lukang Medicine
7.7.1 Shandong Lukang Medicine Anti-infective API Corporation Information
7.7.2 Shandong Lukang Medicine Anti-infective API Product Portfolio
7.7.3 Shandong Lukang Medicine Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Shandong Lukang Medicine Main Business and Markets Served
7.7.5 Shandong Lukang Medicine Recent Developments/Updates
7.8 Zhuhai United Laboratories
7.8.1 Zhuhai United Laboratories Anti-infective API Corporation Information
7.8.2 Zhuhai United Laboratories Anti-infective API Product Portfolio
7.8.3 Zhuhai United Laboratories Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Zhuhai United Laboratories Main Business and Markets Served
7.7.5 Zhuhai United Laboratories Recent Developments/Updates
7.9 Lunan Pharmaceutical Group
7.9.1 Lunan Pharmaceutical Group Anti-infective API Corporation Information
7.9.2 Lunan Pharmaceutical Group Anti-infective API Product Portfolio
7.9.3 Lunan Pharmaceutical Group Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Lunan Pharmaceutical Group Main Business and Markets Served
7.9.5 Lunan Pharmaceutical Group Recent Developments/Updates
7.10 Sandoz
7.10.1 Sandoz Anti-infective API Corporation Information
7.10.2 Sandoz Anti-infective API Product Portfolio
7.10.3 Sandoz Anti-infective API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Sandoz Main Business and Markets Served
7.10.5 Sandoz Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Anti-infective API Industry Chain Analysis
8.2 Anti-infective API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Anti-infective API Production Mode & Process
8.4 Anti-infective API Sales and Marketing
8.4.1 Anti-infective API Sales Channels
8.4.2 Anti-infective API Distributors
8.5 Anti-infective API Customers
9 Anti-infective API Market Dynamics
9.1 Anti-infective API Industry Trends
9.2 Anti-infective API Market Drivers
9.3 Anti-infective API Market Challenges
9.4 Anti-infective API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Anti-infective API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Anti-infective API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Anti-infective API Production Capacity (Kiloton) by Manufacturers in 2023
Table 4. Global Anti-infective API Production by Manufacturers (2019-2024) & (Kiloton)
Table 5. Global Anti-infective API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-infective API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Anti-infective API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Anti-infective API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-infective API as of 2023)
Table 10. Global Market Anti-infective API Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Anti-infective API Production Sites and Area Served
Table 12. Manufacturers Anti-infective API Product Types
Table 13. Global Anti-infective API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Anti-infective API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Anti-infective API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Anti-infective API Production Value Market Share by Region (2019-2024)
Table 18. Global Anti-infective API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Anti-infective API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Anti-infective API Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 21. Global Anti-infective API Production (Kiloton) by Region (2019-2024)
Table 22. Global Anti-infective API Production Market Share by Region (2019-2024)
Table 23. Global Anti-infective API Production (Kiloton) Forecast by Region (2025-2030)
Table 24. Global Anti-infective API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Anti-infective API Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Anti-infective API Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Anti-infective API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 28. Global Anti-infective API Consumption by Region (2019-2024) & (Kiloton)
Table 29. Global Anti-infective API Consumption Market Share by Region (2019-2024)
Table 30. Global Anti-infective API Forecasted Consumption by Region (2025-2030) & (Kiloton)
Table 31. Global Anti-infective API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Anti-infective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 33. North America Anti-infective API Consumption by Country (2019-2024) & (Kiloton)
Table 34. North America Anti-infective API Consumption by Country (2025-2030) & (Kiloton)
Table 35. Europe Anti-infective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 36. Europe Anti-infective API Consumption by Country (2019-2024) & (Kiloton)
Table 37. Europe Anti-infective API Consumption by Country (2025-2030) & (Kiloton)
Table 38. Asia Pacific Anti-infective API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 39. Asia Pacific Anti-infective API Consumption by Region (2019-2024) & (Kiloton)
Table 40. Asia Pacific Anti-infective API Consumption by Region (2025-2030) & (Kiloton)
Table 41. Latin America, Middle East & Africa Anti-infective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 42. Latin America, Middle East & Africa Anti-infective API Consumption by Country (2019-2024) & (Kiloton)
Table 43. Latin America, Middle East & Africa Anti-infective API Consumption by Country (2025-2030) & (Kiloton)
Table 44. Global Anti-infective API Production (Kiloton) by Type (2019-2024)
Table 45. Global Anti-infective API Production (Kiloton) by Type (2025-2030)
Table 46. Global Anti-infective API Production Market Share by Type (2019-2024)
Table 47. Global Anti-infective API Production Market Share by Type (2025-2030)
Table 48. Global Anti-infective API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Anti-infective API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Anti-infective API Production Value Share by Type (2019-2024)
Table 51. Global Anti-infective API Production Value Share by Type (2025-2030)
Table 52. Global Anti-infective API Price (US$/Ton) by Type (2019-2024)
Table 53. Global Anti-infective API Price (US$/Ton) by Type (2025-2030)
Table 54. Global Anti-infective API Production (Kiloton) by Application (2019-2024)
Table 55. Global Anti-infective API Production (Kiloton) by Application (2025-2030)
Table 56. Global Anti-infective API Production Market Share by Application (2019-2024)
Table 57. Global Anti-infective API Production Market Share by Application (2025-2030)
Table 58. Global Anti-infective API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Anti-infective API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Anti-infective API Production Value Share by Application (2019-2024)
Table 61. Global Anti-infective API Production Value Share by Application (2025-2030)
Table 62. Global Anti-infective API Price (US$/Ton) by Application (2019-2024)
Table 63. Global Anti-infective API Price (US$/Ton) by Application (2025-2030)
Table 64. North China Pharmaceutical Anti-infective API Corporation Information
Table 65. North China Pharmaceutical Specification and Application
Table 66. North China Pharmaceutical Anti-infective API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. North China Pharmaceutical Main Business and Markets Served
Table 68. North China Pharmaceutical Recent Developments/Updates
Table 69. CSPC Anti-infective API Corporation Information
Table 70. CSPC Specification and Application
Table 71. CSPC Anti-infective API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. CSPC Main Business and Markets Served
Table 73. CSPC Recent Developments/Updates
Table 74. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Corporation Information
Table 75. Harbin Pharmaceutical Group Pharmaceutical General Factory Specification and Application
Table 76. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Harbin Pharmaceutical Group Pharmaceutical General Factory Main Business and Markets Served
Table 78. Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Developments/Updates
Table 79. Henan Huaxing Pharmaceutical Factory Anti-infective API Corporation Information
Table 80. Henan Huaxing Pharmaceutical Factory Specification and Application
Table 81. Henan Huaxing Pharmaceutical Factory Anti-infective API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Henan Huaxing Pharmaceutical Factory Main Business and Markets Served
Table 83. Henan Huaxing Pharmaceutical Factory Recent Developments/Updates
Table 84. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Corporation Information
Table 85. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Specification and Application
Table 86. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Main Business and Markets Served
Table 88. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Developments/Updates
Table 89. Zhangjiakou Diha Pharmaceutical Anti-infective API Corporation Information
Table 90. Zhangjiakou Diha Pharmaceutical Specification and Application
Table 91. Zhangjiakou Diha Pharmaceutical Anti-infective API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Zhangjiakou Diha Pharmaceutical Main Business and Markets Served
Table 93. Zhangjiakou Diha Pharmaceutical Recent Developments/Updates
Table 94. Shandong Lukang Medicine Anti-infective API Corporation Information
Table 95. Shandong Lukang Medicine Specification and Application
Table 96. Shandong Lukang Medicine Anti-infective API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Shandong Lukang Medicine Main Business and Markets Served
Table 98. Shandong Lukang Medicine Recent Developments/Updates
Table 99. Zhuhai United Laboratories Anti-infective API Corporation Information
Table 100. Zhuhai United Laboratories Specification and Application
Table 101. Zhuhai United Laboratories Anti-infective API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Zhuhai United Laboratories Main Business and Markets Served
Table 103. Zhuhai United Laboratories Recent Developments/Updates
Table 104. Lunan Pharmaceutical Group Anti-infective API Corporation Information
Table 105. Lunan Pharmaceutical Group Specification and Application
Table 106. Lunan Pharmaceutical Group Anti-infective API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Lunan Pharmaceutical Group Main Business and Markets Served
Table 108. Lunan Pharmaceutical Group Recent Developments/Updates
Table 109. Sandoz Anti-infective API Corporation Information
Table 110. Sandoz Specification and Application
Table 111. Sandoz Anti-infective API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. Sandoz Main Business and Markets Served
Table 113. Sandoz Recent Developments/Updates
Table 114. Key Raw Materials Lists
Table 115. Raw Materials Key Suppliers Lists
Table 116. Anti-infective API Distributors List
Table 117. Anti-infective API Customers List
Table 118. Anti-infective API Market Trends
Table 119. Anti-infective API Market Drivers
Table 120. Anti-infective API Market Challenges
Table 121. Anti-infective API Market Restraints
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-infective API
Figure 2. Global Anti-infective API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Anti-infective API Market Share by Type: 2023 VS 2030
Figure 4. β-lactam Drugs Product Picture
Figure 5. Macrolides Product Picture
Figure 6. Carbapenems Product Picture
Figure 7. Quinolones Product Picture
Figure 8. Global Anti-infective API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 9. Global Anti-infective API Market Share by Application: 2023 VS 2030
Figure 10. Antibacterial Drugs for Systemic Use
Figure 11. Antiviral Drugs for Systemic Use
Figure 12. Antigen for Whole Body
Figure 13. Bacteria
Figure 14. Immune Serum and Immunoglobulin
Figure 15. Anti-mycobacterial Drugs
Figure 16. Vaccine
Figure 17. Other
Figure 18. Global Anti-infective API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Anti-infective API Production Value (US$ Million) & (2019-2030)
Figure 20. Global Anti-infective API Production Capacity (Kiloton) & (2019-2030)
Figure 21. Global Anti-infective API Production (Kiloton) & (2019-2030)
Figure 22. Global Anti-infective API Average Price (US$/Ton) & (2019-2030)
Figure 23. Anti-infective API Report Years Considered
Figure 24. Anti-infective API Production Share by Manufacturers in 2023
Figure 25. Anti-infective API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. The Global 5 and 10 Largest Players: Market Share by Anti-infective API Revenue in 2023
Figure 27. Global Anti-infective API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 28. Global Anti-infective API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. Global Anti-infective API Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
Figure 30. Global Anti-infective API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. North America Anti-infective API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 32. Europe Anti-infective API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 33. China Anti-infective API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 34. Japan Anti-infective API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 35. Global Anti-infective API Consumption by Region: 2019 VS 2023 VS 2030 (Kiloton)
Figure 36. Global Anti-infective API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 37. North America Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 38. North America Anti-infective API Consumption Market Share by Country (2019-2030)
Figure 39. Canada Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 40. U.S. Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 41. Europe Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 42. Europe Anti-infective API Consumption Market Share by Country (2019-2030)
Figure 43. Germany Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 44. France Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 45. U.K. Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 46. Italy Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 47. Russia Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 48. Asia Pacific Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 49. Asia Pacific Anti-infective API Consumption Market Share by Regions (2019-2030)
Figure 50. China Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 51. Japan Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 52. South Korea Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 53. China Taiwan Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 54. Southeast Asia Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 55. India Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 56. Latin America, Middle East & Africa Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 57. Latin America, Middle East & Africa Anti-infective API Consumption Market Share by Country (2019-2030)
Figure 58. Mexico Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 59. Brazil Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 60. Turkey Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 61. GCC Countries Anti-infective API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 62. Global Production Market Share of Anti-infective API by Type (2019-2030)
Figure 63. Global Production Value Market Share of Anti-infective API by Type (2019-2030)
Figure 64. Global Anti-infective API Price (US$/Ton) by Type (2019-2030)
Figure 65. Global Production Market Share of Anti-infective API by Application (2019-2030)
Figure 66. Global Production Value Market Share of Anti-infective API by Application (2019-2030)
Figure 67. Global Anti-infective API Price (US$/Ton) by Application (2019-2030)
Figure 68. Anti-infective API Value Chain
Figure 69. Anti-infective API Production Process
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Distributors Profiles
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
